Abstract
A hepatoblastoma in a 6 - month - old child was initially considered unresectable because of diffuse liver
involvement. The patient received 4 courses of cisplatin with an interval time of 2 weeks. A computed tomography
scan after 4 courses of chemotherapy showed shrinking of the tumor, which made it resectable, and the tumor
was removed by central hepatectomy. The patient was able to eat a regular diet on the fourth day and was
sent discharge on the seventh day, after the operation. The pediatric oncologist followed the patient with liver
ultrasonography and alpha - fetoprotein and administered 2 more cycles of cisplatin.
References
Darbari A, Sabin KM, Shapiro CN, Schwarz KB.
Epidemiology of primary hepatic malignancies in
U.S. children. Hepatology. 2003 Sep;38(3):560-6.
Allan BJ, Parikh PP, Diaz S, Perez EA, Neville
HL, Sola JE. Predictors of survival and incidence
of hepatoblastoma in the paediatric population.
HPB. 2013 Oct;15(10):741-6.
Hung GY, Lin LY, Yu TY, Lee CY, Yen HJ,
Horng JL. Hepatoblastoma incidence in Taiwan:
a population - based study. J Chin Med Assoc.
Jun;81(6):541-7
Linabery AM, Ross JA. Trends in childhood
cancer incidence in the U.S. (1992 - 2004).
Cancer. 2008 Jan 15; 112(2):416-32.
Spector LG, Birch J. The epidemiology of
hepatoblastoma. Pediatr Blood Cancer. 2012
Nov; 59(5):776-9.
Malogolowkin MH, Katzenstein HM, Meyers RL,
Krailo MD, Rowland JM, Haas J, et al. Complete
surgical resection is curative for children with
hepatoblastoma with pure fetal histology: a
report from the Children’s Oncology Group. J
Clin Oncol. 2011 Aug 20;29(24):3301-6.
Aronson DC, Meyers RL. Malignant tumors of
the liver in children. Semin Pediatr Surg. 2016
Oct; 25(5):265-75.
Guérin F, Gauthier F, Martelli H, Fabre M,
Baujard C, Franchi S, et al. Outcome of central
hepatectomy for hepatoblastomas. J Pediatr
Surg. 2010 Mar; 45(3):555-63.
Magrath I, Steliarova-Foucher E, Epelman S,
Ribeiro RC, Harif M, Li CK, et al. Paediatric cancer
in low-income and middle - income countries.
Lancet Oncol. 2013 Mar;14(3):e104-16.
Czauderna P, Otte JB, Aronson DC, Gauthier
F, Mackinlay G, Roebuck D, et al. Guidelines
for surgical treatment of hepatoblastoma
in the modern era: recommendations from
the childhood liver tumour strategy group
of the international society of paediatric
oncology (SIOPEL). Eur J Cancer. 2005
May;41(7):1031-6.
Dall’Igna P, Brugieres L, Christin AS, Maibach
R, Casanova M, Alaggio R, et al. Hepatoblastoma
in children aged less than six months at diagnosis:
a report from the SIOPEL group. Pediatr Blood
Cancer. 2018 Jan;65(1).
Fegiz G, Rosati D, Tonelli F, Donfrancesco
A. A case report of hepatoblastoma treated by
chemotherapy and hepatic lobectomy. World J
Surg. 1977 May; 1(3):407-14.
Perilongo G, Maibach R, Shafford E, Brugieres
L, Brock P, Morland B, et al. Cisplatin versus
cisplatin plus doxorubicin for standard-risk
hepatoblastoma. N Engl J Med. 2009 Oct
;361(17):1662-70.
La Quaglia MP, Shorter NA, Blumgart LH.
Central hepatic resection for pediatric tumors. J
Pediatr Surg. 2002 Jul;37(7):986-9.
Ohno Y, Furui J, Kanematsu T. Is a modified
central bisegmentectomy a volume - saving
operation for pediatric hepatoblastoma? J Pediatr
Surg. 2004 Jan;39(1):E13-6.
Li J, Li H, Wu H, Niu H, Li H, Pan J, et al.
Outcomes of children with hepatoblastoma who
underwent liver resection at a tertiary hospital
in China: a retrospective analysis. BMC Pediatr.
May 9;20(1):200
Published | 29-11-2021 | |
Fulltext |
|
|
Language |
|
|
Issue | No. 74 (2021) | |
Section | Case report | |
DOI | ||
Keywords | Cắt gan trung tâm, U nguyên bào gan, trẻ em. Central Hepatectomy, Hepatoblastoma, children. |

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2021 Journal of Clinical Medicine Hue Central Hospital